Skip to content
akaturk Academic measurement
Articles 11 YÖKSİS 11 · OpenAlex 0 Total citations 223 h-index 7 · OpenAlex Q1 articles 2 Scopus · WoS Q1 1 Best field rank #92 / 273 Side field · top 33.7% Co-authors 4 1 Turkish institutions
  1. Ana Dal Sağlık Bilimleri Temel Alanı
  2. Yan Dal Farmasotik Teknoloji
Academic summary YÖKSİS and OpenAlex counted separately.
Articles 11
YÖKSİS11 OpenAlex0
Projects 0
Books 1
Proceedings 0

Citation impact

OpenAlex YÖKSİS articles matched in OpenAlex: 11
h-index 7 Percentile in Türkiye: 74 #119 of 316 at their university by h-index
i10-index
7
Total citations
223
Top 23% in Türkiye
Per article
20.3
FWCI
0.73
1.00 = world average
World top 1%
0
World top 10%
0

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included.

Field ranking

YÖKSİS ?

Collaboration network

From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.

Co-authors
4
With an akaturk profile
2
Turkish institutions
1
Co-authored works
%18

Academic co-authors 2

  1. AYŞENUR KILIÇ Araştırma Görevlisi · Bezm-İ Âlem Vakıf Üniversitesi same university 1
  2. MELİKE ÜNER Profesör · İstanbul Sağlık Ve Teknoloji Üniversitesi 1

National collaboration 1 institutions

Within own university1 joint works · Bezm-İ Âlem Vakıf Üniversitesi

  1. İstanbul Sağlık Ve Teknoloji Üniversitesi 1 works · 1 academics

Other co-authors (incl. international) 2

ASLI BARLA DEMİRKOZSAMET ÖZDEMİR

Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.

Index quartiles

?
Scopus (SJR) 10
  • Q1 2 %20.0
  • Q2 8 %80.0
  • Q3 0 %0.0
  • Q4 0 %0.0
WoS (JCR) 11
  • Q1 1 %9.1
  • Q2 4 %36.4
  • Q3 4 %36.4
  • Q4 2 %18.2
TR Index 1 articles
OpenAlex citation percentile
Top 1%0
Top 10%0
Avg · n 12 %59.3
Other counts

Scopus (SJR)

  • YÖKSİS rows 11

WoS (JCR)

  • YÖKSİS rows 12

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

11articles

Journals with publications

10 journals

Narrow down

Scopus (SJR)
Q12 Q28 Q30 Q40
WoS (JCR)
TR Index

Article list

  1. 2025 Optimization of cleansing oil formulation containing polyglyceryl-6 caprylate and polyglyceryl-4 caprate using the response surface method ISTANBUL JOURNAL OF PHARMACY DOI 10.26650/IstanbulJPharm.2025.1506618 YÖKSİS TR Index JCR Q4 OpenAlex 4.8%
  2. 2021 Evaluation of wound healing potential of new composite liposomal films containing coenzyme Q10 and d-panthenyl triacetate as combinational treatment PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY DOI 10.1080/10837450.2021.1887892 YÖKSİS SJR Q2 JCR Q2 OpenAlex 46.7%
  3. 2020 Targeted Nanomedicines for Cancer Therapy, From Basics to Clinical Trials Journal of Pharmacy & Pharmaceutical Sciences DOI 10.18433/jpps30583 YÖKSİS SJR Q2 JCR Q3 OpenAlex 75.6%
  4. 2020 Inhibition of Amyloid β Aggregation Using Optimized Nano-Encapsulated Formulations of Plant Extracts with High Metal Chelator Activities Current Pharmaceutical Biotechnology DOI 10.2174/1389201021666191210125851 YÖKSİS SJR Q2 JCR Q3 OpenAlex 62.6%
  5. 2020 INFLUENCE OF VEHICLES AND PENETRATION ENHANCERS ON ANTI-INFLAMMATORY EFFECT OF 18-β GLYCYRRHETINIC ACID: KINETIC MODELLING OF DRUG RELEASE, IN VIVO AND EX VIVO EXPERIMENTS FARMACIA DOI 10.31925/farmacia.2020.4.9 YÖKSİS SJR Q2 JCR Q4 OpenAlex 38.0%
  6. 2018 Eplerenone nanoemulsions for treatment of hypertension. Part I: Experimental design for optimization of formulations and physical characterization Journal of Drug Delivery Science and Technology DOI 10.1016/j.jddst.2018.03.011 YÖKSİS SJR Q2 JCR Q2 OpenAlex 63.8%
  7. 2018 Eplerenone nanoemulsions for treatment of hypertension. Part II: Physical stability assessment and in vivo study Journal of Drug Delivery Science and Technology DOI 10.1016/j.jddst.2018.03.014 YÖKSİS SJR Q2 JCR Q2 OpenAlex 77.0%
  8. 2018 Therapeutic Potential of Drug Delivery by Means of Lipid Nanoparticles: Reality or İllusion? Current Pharmaceutical Design DOI 10.2174/1381612823666171122110638 YÖKSİS SJR Q2 JCR Q3 OpenAlex 53.6%
  9. 2017 Risperidone mucoadhesive buccal tablets: formulation design, optimization and evaluation Drug Design, Development and Therapy DOI 10.2147/DDDT.S150774 YÖKSİS SJR Q1 JCR Q2 OpenAlex 79.3%
  10. 2017 Optimization of piribedil mucoadhesive tablets for efficient therapy of Parkinson\u2019s disease: physical characterization and ex vivo drug permeation through buccal mucosa Drug Development and Industrial Pharmacy DOI 10.1080/03639045.2017.1349785 2 YÖKSİS records YÖKSİS SJR Q2 JCR Q3 OpenAlex 66.0%
  11. 2017 Design, optimization and characterization of coenzyme Q10- and D-panthenyl triacetate-loaded liposomes International Journal of Nanomedicine DOI 10.2147/IJN.S140835 YÖKSİS SJR Q1 JCR Q1 OpenAlex 78.7%

← Back to academicians